SEC Filing Summary: SPACEHAB, Incorporated (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by SPACEHAB, Incorporated on October 22, 2007, reporting an event that occurred on October 19, 2007. The registrant is headquartered in Webster, Texas. Note: The request metadata referenced "ASTROTECH Corp," but the filing text explicitly identifies the registrant as SPACEHAB, Incorporated.
Key Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
The material change reported is the resignation of Myron J. Goins as a director, effective October 16, 2007. This resignation resulted in the Company failing to meet NASDAQ Marketplace Rule 4350(c)(1) (requiring a majority of independent directors) and Rule 4350(d)(4) (requiring three independent directors on the audit committee).
Outlook, Risks, and Contingencies
Cure Period: NASDAQ has granted the Company a cure period to regain compliance. The deadline is the earlier of the next annual shareholders' meeting or October 16, 2008. If the next annual meeting occurs before April 14, 2008, compliance must be evidenced by April 14, 2008.
Risk of Delisting: If the Company fails to regain compliance within the cure period, its common stock is subject to delisting from the NASDAQ Stock Market. This determination may be appealed.
Disclosure: A press release announcing this event was issued on October 22, 2007, in compliance with Marketplace Rule 4803(a).
Investor Verification Checklist
- Verify the current composition of the Board of Directors to confirm if the independent director requirement has been met.
- Confirm the date of the next annual shareholders' meeting to determine the exact compliance deadline.
- Monitor for any subsequent filings regarding the Company's status with NASDAQ or potential delisting notices.
- Review the attached press release (Exhibit 99.1) for additional management commentary on the resignation.